All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@drrobkominiarek's marijuana and testosterone claims checked

Rob Kominiarek

Instagram creator

22.7K viewsView on Instagram→

Quick answer

Chronic, frequent cannabis use has been associated with suppressed testosterone and disrupted gonadotropin signaling in human studies, though causality is not firmly established and effects may be reversible with cessation. In men presenting with low T symptoms, cannabis use history is a relevant variable in the clinical workup, particularly given its potential to interact with HPA axis function and anxiety regulation. Clinicians evaluating younger men for hypogonadism should include cannabis frequency and formulation type in their intake assessment, alongside standard confounders like BMI, sleep quality, and alcohol use.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @drrobkominiarek actually say?

The claim is blunt: marijuana is "a toxin that negatively impacts the hypothalamic pituitary axis" and regular use will cause low testosterone. He goes further, saying that even THC supplements suppress testosterone and should be avoided entirely. He also draws a specific dose-response line, arguing that occasional use won't cause lasting harm, but smoking three times a week will reliably produce low T. That last point, the frequency threshold, is actually worth examining separately because it's the most testable claim in the video.

He also connects the dots to anxiety, arguing that young men are self-medicating with cannabis for anxiety, which then lowers testosterone, which then worsens anxiety, creating a feedback loop. That's a more nuanced clinical observation than the headline claim, and it deserves more credit than the rest of the video gives it.

Does the science back this up?

Partially, and more conditionally than the video admits. The evidence that cannabis suppresses testosterone exists, but it's messier than "smoke marijuana, you will have low testosterone." The relationship appears dose-dependent and may be reversible, which matters enormously for clinical framing.

A 2017 study by Thistle et al. in the American Journal of Epidemiology found that men who used cannabis more than once a week had significantly lower sperm concentration and total sperm count, suggesting reproductive endocrine disruption. Earlier work by Kolodny et al. (1974, New England Journal of Medicine) found chronic heavy users had significantly lower testosterone than non-users, though that study had methodological limitations. More recently, Gundersen et al. (2015, American Journal of Epidemiology) found that recent cannabis use was associated with lower sperm counts in young Danish men. The HPA axis suppression angle he mentions has some support in animal models, but human data is more equivocal. A 2019 review by Cuttler et al. in Psychoneuroendocrinology found inconsistent effects on cortisol and HPA axis reactivity in humans, making the "period, full stop" framing an overreach.

What did they get wrong (or right)?

He got the general direction right: chronic, frequent cannabis use is associated with lower testosterone and reproductive hormone disruption in men. That's supported by real data. The frequency heuristic, that occasional use probably won't cause lasting suppression, also has some biological plausibility given the reversibility data.

Where the video goes wrong is the certainty. Saying marijuana "is a toxin" that will definitively give you low testosterone if you smoke three times a week treats association as causation and ignores confounders. Many studies on cannabis and testosterone don't control adequately for lifestyle factors, body composition, alcohol use, or sleep, all of which independently affect testosterone. The claim that THC supplements will lower testosterone "even like THC supplements" is stated without any supporting evidence and conflates dosage forms with effects. Oral THC pharmacokinetics differ substantially from smoked cannabis. He's not wrong to flag concern, but the certainty level in the transcript is not matched by the certainty level in the literature.

  • Right: chronic heavy use is associated with lower testosterone
  • Right: the HPA axis is a plausible mechanism
  • Wrong: the causal certainty he projects is not in the data
  • Wrong: no meaningful distinction made between THC dose forms
  • Unverifiable: the three-times-per-week threshold is clinically invented

What should you actually know?

If you're a man under 40 with symptoms of low testosterone and you're using cannabis regularly, it's a legitimate variable worth discussing with a clinician. The evidence isn't strong enough to say cannabis caused your low T, but it's strong enough to say stopping regular use and retesting is a reasonable clinical step before assuming you need TRT.

The anxiety loop he describes is clinically plausible and probably underappreciated. Low testosterone can worsen anxiety, cannabis is frequently used to self-medicate anxiety, and if cannabis is suppressing testosterone even modestly, you may be making the underlying problem worse. That feedback dynamic is worth taking seriously. But "avoid it all together" applied universally, including to medicinal THC products, ignores legitimate clinical contexts and is not a one-size-fits-all recommendation. Anyone concerned about low testosterone symptoms should get a full hormone panel, including LH and FSH, not just total testosterone, before drawing conclusions about cannabis as the cause.

Bottom line

This video sits in the category of a real concern overstated with false precision. The core worry, that heavy cannabis use may suppress testosterone in younger men, is worth raising. The certainty with which it's delivered, including the three-times-a-week rule and the blanket condemnation of all THC products, goes beyond what the current evidence supports. Clinicians flagging cannabis as a variable in low T workups are doing the right thing. Telling patients that smoking three times a week will definitively cause low testosterone is a different claim, and it's one the literature does not cleanly support.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @drrobkominiarek's marijuana and testosterone claims checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@drrobkominiarek's marijuana and testosterone claims checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Chronic, frequent cannabis use has been associated with suppressed testosterone and disrupted gonadotropin signaling in human studies, though causality is not firmly established and effects may be reversible with cessation.

FormBlends verdict

Chronic, frequent cannabis use has been associated with suppressed testosterone and disrupted gonadotropin signaling in human studies, though causality is not firmly established and effects may be reversible with cessation. In men presenting with low T symptoms, cannabis use history is a relevant variable in the clinical workup, particularly given its potential to interact with HPA axis function and anxiety regulation. Clinicians evaluating younger men for hypogonadism should include cannabis frequency and formulation type in their intake assessment, alongside standard confounders like BMI, sleep quality, and alcohol use.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Chronic, frequent cannabis use has been associated with suppressed testosterone and disrupted gonadotropin signaling in human studies, though causality is not firmly established and effects may be reversible with cessation. In men presenting with low T symptoms, cannabis use history is a relevant variable in the clinical workup, particularly given its potential to interact with HPA axis function and anxiety regulation. Clinicians evaluating younger men for hypogonadism should include cannabis frequency and formulation type in their intake assessment, alongside standard confounders like BMI, sleep quality, and alcohol use.
  • A 2015 study (Gundersen et al., American Journal of Epidemiology) found recent cannabis use was associated with lower sperm counts in young men, consistent with reproductive endocrine disruption.
  • The original Kolodny et al. 1974 NEJM study found chronic heavy users had significantly lower testosterone, but methodological limitations including small sample size and poor confounder control limit its strength.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • A 2015 study (Gundersen et al., American Journal of Epidemiology) found recent cannabis use was associated with lower sperm counts in young men, consistent with reproductive endocrine disruption.
  • The original Kolodny et al. 1974 NEJM study found chronic heavy users had significantly lower testosterone, but methodological limitations including small sample size and poor confounder control limit its strength.
  • No peer-reviewed study has established three times per week as a clinically meaningful threshold for cannabis-induced testosterone suppression.
  • Testosterone suppression from cannabis may be reversible with cessation, which is a clinically important distinction from permanent hypogonadism requiring TRT.
  • Oral and inhaled THC have different pharmacokinetic profiles; blanket warnings about all THC formulations are not supported by the inhaled cannabis literature alone.
  • Men with low T symptoms who use cannabis regularly should get a full hormone panel including LH, FSH, and total and free testosterone before attributing low T to any single cause.
  • The anxiety-low testosterone feedback loop the creator describes is clinically plausible based on bidirectional hormone-mood research, even if the specific cannabis component is not directly studied in this context.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Rob Kominiarek · Instagram creator

22.7K views on this video

I believe one of the reasons men under 40 are struggling with low testosterone is because so many men nowadays are smoking mariju@n@... and on a regular basis.  Check out today’s reel to learn more a

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Rob Kominiarek, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.